Role of GPER on proliferation, migration and invasion in ligand-independent manner in human ovarian cancer cell line SKOV3

被引:37
|
作者
Yan, Yan [1 ]
Jiang, Xueli [1 ]
Zhao, Ying [1 ]
Wen, Haixia [1 ]
Liu, Guoyi [1 ]
机构
[1] Harbin Med Univ, Dept Physiol, Lab Reprod Endocrinol, Harbin 150081, Peoples R China
关键词
G protein-coupled estrogen receptor; ER alpha; ER beta; ovarian cancer; proliferation; migration; invasion; ESTROGEN-RECEPTOR-ALPHA; G-1 SUPPRESSES PROLIFERATION; GENE-EXPRESSION CHANGES; AGONIST G-1; GROWTH-RESPONSE; BETA; 17-BETA-ESTRADIOL; ACTIVATION; SURVIVAL; PATHWAY;
D O I
10.1002/cbf.3154
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
G protein-coupled estrogen receptor (GPER) is identified as a critical estrogen receptor, in addition to the classical estrogen receptors ER alpha and ER beta. In ER alpha-negative ovarian cancer cells, our previous studies have found that estrogen stimulated cell proliferation and metastasis via GPER. However, the ligand-independent function of GPER in ovarian cancer cells is still not clear. Herein, we describe that GPER has a co-expression with ER alpha and ER beta, which are first determined in SKOV3 ovarian cancer cell line. In the absence of estrogen, GPER depletion by specific siRNA inhibits the proliferation, migration and invasion of SKOV3 cells. Whereas abrogation of ER alpha or ER beta by specific antagonist MPP and PHTPP has the opposite effects for stimulation of cell growth. Markedly, GPER knockdown attenuates MPP or PHTPP-induced cell proliferation, migration and invasion. Furthermore, GPER modulates protein expression of the cell cycle critical components, c-fos and cyclin D1 and factors for cancer cell invasion and metastasis, matrix metalloproteinase 2 (MMP-2) and MMP-9. These findings establish that GPER ligand-independently stimulates the proliferation, migration and invasion of SKOV3 cells. Knockdown of GPER attenuates the progression of ovarian cancer that caused by functional loss of ER alpha or ER beta. Targeting GPER provides new aspect as a potential therapeutic strategy in ovarian cancer. Copyright (C) 2015 John Wiley & Sons, Ltd.
引用
收藏
页码:552 / 559
页数:8
相关论文
共 50 条
  • [41] Antiproliferation and Apoptosis Effect of Cisplatin and Nanocurcumin on Ovarian Cancer SKOV3 Cell
    Purbadi, Sigit
    Yusuf, Muhammad
    Arozal, Wawaimuli
    Naroeni, Aroem
    Winarto, Hariyono
    Putra, Andi Darma
    Sotarduga, Gilbert Elia
    BALI MEDICAL JOURNAL, 2022, 11 (01) : 377 - 381
  • [42] Silencing MARCH1 suppresses proliferation, migration and invasion of ovarian cancer SKOV3 cells via downregulation of NF-κB and Wnt/β-catenin pathways
    Meng, Ying
    Hu, Jianguo
    Chen, Yuhong
    Yu, Tinghe
    Hu, Lina
    ONCOLOGY REPORTS, 2016, 36 (05) : 2463 - 2470
  • [43] A new methodology for controlling mutagens using cancer cell line SKOV3
    Chousmekeridou, A.
    Lialiaris, E. T.
    Asimakopoulos, B.
    Sandaltzopoulos, R.
    Lialiaris, T. S.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2018, 26 : 658 - 658
  • [44] THE VITAMIN D RECEPTOR HAS A LIGAND-INDEPENDENT ROLE IN HUMAN BREAST CANCER CELL GROWTH
    Zheng, Y.
    Trivedi, T.
    Ooi, L.
    Fong-Yee, C.
    Dunstan, C. R.
    Seibel, M.
    Zhou, H.
    OSTEOPOROSIS INTERNATIONAL, 2011, 22 : S598 - S599
  • [45] The role of Crk/Dock180/Rac1 pathway in the malignant behavior of human ovarian cancer cell SKOV3
    Wang, Hui
    Linghu, Hua
    Wang, Jin
    Che, Ya-ling
    Xiang, Ting-xiu
    Tang, Wei-xue
    Yao, Zhen-wei
    TUMOR BIOLOGY, 2010, 31 (01) : 59 - 67
  • [46] Curcumin inhibits invasion and metastasis in the human ovarian cancer cells SKOV3 by CXCL12-CXCR4 axis
    Mu Xiaoling
    Zhao Jing
    Xu Fang
    Tang Liangdan
    AFRICAN JOURNAL OF BIOTECHNOLOGY, 2010, 9 (48): : 8230 - 8234
  • [47] The Depressive Effect Study of 125I Labeled Antisense Peptide Nucleic Acid on Human Ovarian Cancer Cell Line SKOV3
    Zhang, B.
    Hu, J.
    Huang, H.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 : S196 - S197
  • [48] Effects and mechanisms of chloroquine alone and in combination with cisplatin in the treatment of human ovarian cancer cell SKOV3 in vitro
    Wang, Jingru
    Zhang, Haiyan
    Sun, Hong
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2017, 10 (06): : 6645 - 6654
  • [49] Combined Usage of MDK Inhibitor Augments Interferon-γ Anti-Tumor Activity in the SKOV3 Human Ovarian Cancer Cell Line
    Liu, Qun
    Tan, Jingyu
    Zhao, Zhenguo
    Li, Ruijun
    Zheng, Luyu
    Chen, Xiangyu
    Li, Lina
    Dong, Xichen
    Wen, Tao
    Liu, Jian
    BIOMEDICINES, 2023, 11 (01)
  • [50] Human interleukin-2 gene transfer into ovarian cancer cell lines SKOV3, decreased the proliferation, tumorigenesis and enhanced the immunity of the tumor cells
    ZhenYu Zhang Ning Guo JingHe Lang Ning MaoPeiHsien TangBeijing Institute of Basic Medical Sciences Beijing
    实验血液学杂志, 1997, (03) : 308 - 308